Titan Pharmaceuticals
TTNP
#10596
Rank
โ‚น0.58 B
Marketcap
โ‚น436.57
Share price
-3.76%
Change (1 day)
27.71%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น415.73. In 2023 the company made an earnings per share (EPS) of -โ‚น701.73 an increase over its 2022 EPS that were of -โ‚น1,438.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น701.73-51.22%
2022-โ‚น1,438-15.61%
2021-โ‚น1,705-81.37%
2020-โ‚น9,148-77.52%
2019-โ‚น40,702-56.32%
2018-โ‚น93,186-59.51%
2017-โ‚น2,30,169-371.81%
2016โ‚น84,679-144.35%
2015-โ‚น1,90,917300%
2014-โ‚น47,729-121.54%
2013โ‚น2,21,600-151.38%
2012-โ‚น4,31,268-11.54%
2011-โ‚น4,87,520188.89%
2010-โ‚น1,68,757-10%
2009-โ‚น1,87,508
2007-โ‚น7,68,781-2.38%
2006-โ‚น7,87,532-39.13%
2005-โ‚น12,93,803-16.87%
2004-โ‚น15,56,314-22.43%
2003-โ‚น20,06,3324.9%
2002-โ‚น19,12,57861.9%
2001-โ‚น11,81,298-13.7%
2000-โ‚น13,68,80665.01%
1999-โ‚น8,29,543-35.87%
1998-โ‚น12,93,582-1824.71%
1997โ‚น75,003-102.4%
1996-โ‚น31,31,378

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น827.33-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น664.79-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น134.47-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น87.12-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.67-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น368.38-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA